Volume 40, Issue 9 e15077
RESEARCH: BASIC SCIENCE

Up-regulation of miR-192-5p inhibits the ELAVL1/PI3Kδ axis and attenuates microvascular endothelial cell proliferation, migration and angiogenesis in diabetic retinopathy

Xiao-Lin Fu

Xiao-Lin Fu

Department of Ophthalmology, Hainan West Central Hospital, Danzhou, Hainan Province, P.R. China

Search for more papers by this author
Fu-Tao He

Corresponding Author

Fu-Tao He

Department of Ophthalmology, Hainan West Central Hospital, Danzhou, Hainan Province, P.R. China

Correspondence

Fu-Tao He, Department of Ophthalmology, Hainan West Central Hospital, No. 2 Fubo East Road, Nada Town, Danzhou 571700, Hainan Province, P.R. China.

Email: [email protected]

Search for more papers by this author
Mo-Han Li

Mo-Han Li

Department of Ophthalmology, Hainan West Central Hospital, Danzhou, Hainan Province, P.R. China

Search for more papers by this author
Chun-Yan Fu

Chun-Yan Fu

Department of Ophthalmology, Hainan West Central Hospital, Danzhou, Hainan Province, P.R. China

Search for more papers by this author
Jian-Zhi Chen

Jian-Zhi Chen

Department of Ophthalmology, Hainan West Central Hospital, Danzhou, Hainan Province, P.R. China

Search for more papers by this author
First published: 02 March 2023

Xiao-Lin Fu and Fu-Tao He are co-first authors.

Abstract

Background

Diabetic retinopathy (DR) is a common complication of diabetes mellitus that poses a threat to adults. MicroRNAs (miRNAs) play a key role in DR progression. However, the role and mechanism of miR-192-5p in DR remain unclear. We aimed to investigate the effect of miR-192-5p on cell proliferation, migration and angiogenesis in DR.

Methods

Expression of miR-192-5p, ELAV-like RNA binding protein 1 (ELAVL1) and phosphoinositide 3-kinase delta (PI3Kδ) in human retinal fibrovascular membrane (FVM) samples and human retinal microvascular endothelial cells (HRMECs) was assessed using RT-qPCR. ELAVL1 and PI3Kδ protein levels were evaluated by Western blot. RIP and dual luciferase reporter assays were performed to confirm the miR-192-5p/ELAVL1/PI3Kδ regulatory networks. Cell proliferation, migration and angiogenesis were assessed by CCK8, transwell and tube formation assays.

Results

MiR-192-5p was decreased in FVM samples from DR patients and high glucose (HG)-treated HRMECs. Functionally, overexpressed miR-192-5p inhibited cell proliferation, migration and angiogenesis in HG-treated HRMECs. Mechanically, miR-192-5p directly targeted ELAVL1 and decreased its expression. We further verified that ELAVL1 bound to PI3Kδ and maintained PI3Kδ mRNA stability. Rescue analysis demonstrated that the suppressive effects of HG-treated HRMECs caused by miR-192-5p up-regulation were overturned by overexpressed ELAVL1 or PI3Kδ.

Conclusion

MiR-192-5p attenuates DR progression by targeting ELAVL1 and reducing PI3Kδ expression, suggesting a biomarker for the treatment of DR.

CONFLICT OF INTEREST STATEMENT

The authors declare that they have no conflict of interest.

DATA AVAILABILITY STATEMENT

All data generated or analysed during this study are included in this article. The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.